利伐沙班上市了吗？售价多少？

(Also known as: Xarelto) is highly effective and is used to prevent venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery. Rivaroxaban is suitable for adults with deep vein thrombosis; for adult patients with non-valvular atrial fibrillation, is rivaroxaban on the market? How much does it cost?

The market price of rivaroxaban: In 2009, rivaroxaban was launched in China and has been included in medical insurance. Specification: 10mg-5 tablets/box, priced at about 138$; Specification: 15mg-7 tablets/box, priced at about 199$; Specification: 20mg-7 tablets/box, priced at about 263$.

Rivaroxaban marketed abroad: specification: 15mg*28 tablets; price of 20mg*28 tablets is around $600. For specific prices, please consult Medical Companion Travel.

Contraindicated groups for rivaroxaban:

1. Patients who are allergic to rivaroxaban or any excipients in the tablets.

2. Patients with clinically obvious active bleeding.

3. Lesions or conditions with a significant risk of major bleeding, such as current or recent gastrointestinal ulcers, malignant tumors with a high risk of bleeding, recent brain or spinal injury, recent brain, spine or eye surgery, recent intracranial hemorrhage, known or suspected esophageal varices, arteriovenous malformations, vascular aneurysms or major intravertebral intracranial vascular malformations.

4. Except in the case of switching from or from other treatments to rivaroxaban, or the administration of unfractionated heparin (UFH) doses required to maintain central venous or arterial catheters, concomitant treatment with any other anticoagulants is prohibited, such as UFH, low molecular weight heparins (enoxaparin, dalteparin, etc.), heparin derivatives (fondaparinux, etc.), oral anticoagulants (warfarin, apixaban, dabigatran, etc.).

5. Patients with liver disease associated with coagulation abnormalities and clinically relevant bleeding risks. It is not suitable for the elderly and is not recommended.